A patient with extensive stem cell factor-induced hyperpigmentation

Cutis

Volumn 71, Issue 2, 2003, Pages 149-152

  Bellet, Jane S ^a   Obadiah, Joseph M ^a   Frothingham, Barbara M ^a   Kurtzberg, Joanne ^a   Grichnik, James M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; COSMETIC; DEFEROXAMINE; STEM CELL FACTOR;

ADULT; ALLERGY; ANAMNESIS; ANAPHYLAXIS; ARTICLE; BLACKFAN DIAMOND ANEMIA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DOSE RESPONSE; DYSPNEA; ERYTHEMA; FEMALE; HUMAN; HYPERPIGMENTATION; INJECTION SITE; PRURITUS; SIDE EFFECT; URTICARIA; CHEMICALLY INDUCED DISORDER; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANEMIA, DIAMOND-BLACKFAN; FEMALE; HUMANS; HYPERPIGMENTATION; INJECTIONS, SUBCUTANEOUS; STEM CELL FACTOR;

EID: 0038819570     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Morstyn G, Brown S, Gordon M, et al. Stem cell factor is a potent synergistic factor in hematopoiesis. Oncology. 1994;51:205-214.
2. Bernstein A, Forrester L, Reith AD, et al. The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin Hematol. 1991;28:138-142.
3. Glaspy JA, Shpall EJ, LeMaistre CF, et al. Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood. 1997;90:2939-2951.
4. Dianzani I, Garelli E, Crescenzio N, et al. Diamond-Blackfan anemia: expansion of erythroid progenitors in vitro by IL-9, but exclusion of a significant pathogenetic role for the IL-9 gene and the hematopoietic gene cluster on chromosome 5q. Exp Hematol. 1997;25:1270-1277.
5. de Vries P, Brasel KA, Eisenman JR. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med. 1991;173:1205-1211.
6. Bodine DM, Seidel NE, Zsebo KM. In vivo administration of SCF to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood. 1993;82:445-455.
7. Lyman SD, Williams DE. Biological activities and potential therapeutic uses of steel factor, a new growth factor active on multiple hematopoietic lineages. Am J Pediatr Hematol Oncol. 1992;14:1-7.
8. Olivieri NF, Grunberger T, Ben-David Y. Diamond Blackfan anemia: heterogeneous response of hematopoietic progenitor cells in vitro to the protein product of the mouse steel locus. Blood. 1991;78:2211-2215.
9. Grichnik JM, Crawford J, Jiminez F, et al. Human recombinant SCF induces melanocytic hyperplasia in susceptible patients. J Amer Acad Dermatol. 1995;33:577-583.
10. Costa JJ, Demetri GD, Harrist TJ, et al. Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med. 1996;183:2681-2686.
11. Columbo M, Horowitz EM, Botana EM, et al. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol. 1992;149:599-608.
12. Costa JJ. Updates on cells and cytokines: the therapeutic use of hematopoietic growth factors. J Allergy Clin Immunol. 1998;101:1-6.
13. Dvorak AM, Costa JJ, Monahan-Earley RA, et al. Ultrastructural analysis of human skin biopsy specimens from patients receiving recombinant human stem cell factor: subcutaneous injection of rhSCF induces dermal mast cell degranulation and granulocyte recruitment at the injection site. J Allergy Clin Immunol. 1998;101:793-806.
14. Funasaka Y, Boulton T, Cobb M, et al. c-KIT kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell. 1992;3:197-209.
15. Grichnik JM, Burch JA, Burchette J, et al. The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol. 1998;111:233-238.
16. Morrelli JG, Norris DA. Influence of inflammatory mediators and cytokines on human melanocyte function. J Invest Dermatol. 1993;100(suppl 2):191S-195S.
17. Ruiz-Maldonado R, Orozco-Covarrubias M. Post-inflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16:36-43.
18. Tomita Y, Maeda K, Tagami H. Histamine stimulates normal human melanocytes in vitro: one of the possible inducers of hyperpigmentation in urticaria pigmentosa. J Dermatol Sci. 1993;6:146-154.
19. Nordlund, JJ, Collins CE, Rheins LA. Prostaglandin E2 and D2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse. J Invest Dermatol. 1986;86:433-437.
20. Lavker RM, Schechter NM. Cutaneous mast cell depletion results from topical corticosteroid usage. J Immunol. 1985;135:2368-2373.
21. Hirobe T. Hydrocortisone is involved in regulating the proliferation and differentiation of mouse epidermal melanoblasts in serum-free culture in the presence of keratinocytes. Eur J Cell Biol. 1996;71:387-394.
22. Smith MA, Pallister CJ, Smith JG. Stem cell factor: biology and relevance to clinical practice. Acta Haematol. 2001;105:143-150.
23. Yamamoto T, Katayama I, Nishioka K. Increased serum level of stem cell factor in association with disease progression of hyperpigmented mycosis fungoides. Br J Dermatol. 1999;140:765-766.
24. Yamamoto T, Sawada Y, Katayama I, et al. Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation. Br J Dermatol. 2001;144:199-200.
25. Shishido E, Kadono S, Manaka I, et al. The mechanism of epidermal hyperpigmentation in dermatofibroma is associated with stem cell factor and hepatocyte growth factor expression. J Invest Dermatol. 2001;117:627-633.